Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review

Brain metastasis from intrahepatic cholangiocarcinoma (iCCA) is extremely rare, and no standard therapeutic strategy has been established. Camrelizumab is a programmed cell death protein 1 (PD-1) inhibitor that has been widely studied in treating liver cancer. Combined immunotherapy and targeted the...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Peiyi, Guo, Lei, Zhang, Bo, Xu, Yongfeng, Song, Qi, Shi, Hongcheng, Ye, Qinghai, Li, Hui, Xiao, Yongsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382583/
https://www.ncbi.nlm.nih.gov/pubmed/35992782
http://dx.doi.org/10.3389/fonc.2022.911202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382583/
https://www.ncbi.nlm.nih.gov/pubmed/35992782
http://dx.doi.org/10.3389/fonc.2022.911202

Ejemplares similares